These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Local chemotherapy in diffuse and local appendical peritonitis, with special attention to elkosin]. HENNICKE W; KERSTNER G Z Arztl Fortbild (Jena); 1956 Feb; 50(3):129-33. PubMed ID: 13325572 [No Abstract] [Full Text] [Related]
6. Sulfadimetine (elkosin) in ophthalmology. HURWITZ P Am J Ophthalmol; 1953 Nov; 36(11):1621-3. PubMed ID: 13104575 [No Abstract] [Full Text] [Related]
7. An evaluation of elkosin, gantrisin and sulfacetamide in standardized infections in mice. WHITE HJ; WADSWORTH BC; REDIN GS; GENTILE AJ Antibiot Chemother (Northfield); 1952 Dec; 2(12):659-77. PubMed ID: 24542157 [No Abstract] [Full Text] [Related]
8. Comparative oral toxicity of 6-sulphonamido-2,4-dimethylpyrimidine (elkosin) and of various sulphonamide combinations. TRIPOD J Arch Int Pharmacodyn Ther; 1953 Jul; 94(3):338-45. PubMed ID: 13093052 [No Abstract] [Full Text] [Related]
9. Elkosin in the management of urinary tract infections. BOGASH M; ELLIS H; MURPHY JJ J Am Med Assoc; 1956 Aug; 161(16):1564-5. PubMed ID: 13345625 [No Abstract] [Full Text] [Related]
11. Therapy with a new sulfonamide triple mixture; sulfadiazine, sulfamerazine, elkosin. LEHR D; TERRANOVA R; BLUMENFELD S; GOLDFARB ML Postgrad Med; 1953 Mar; 13(3):231-38. PubMed ID: 13037579 [No Abstract] [Full Text] [Related]
12. [Experimental studies on the effect of elkosin on the H2S splitting by Escherichia coli bacteria]. TANNERT S Z Gesamte Inn Med; 1952 Nov; 7(22):1042-6. PubMed ID: 13039339 [No Abstract] [Full Text] [Related]
13. [The effect of elkosin on the infected mouse, on the development and oxidation processes of bacteria in the glass in comparison with cibazole]. FREI W; JEZIERSKI A Schweiz Z Pathol Bakteriol; 1946; 9(4):277-90. PubMed ID: 20281315 [No Abstract] [Full Text] [Related]
14. [Experimental and clinical experiences with elkosin, 6-sulfanilamido-2-4-dimethylpyrimidine]. PREUSS HG Munch Med Wochenschr; 1950 Nov; 92(31-32):1301-5. PubMed ID: 14796609 [No Abstract] [Full Text] [Related]
15. Observations on absorption, distribution, and excretion of elkosin (N-[2,6-dimethyl-4-pyrimidyl]-sulfanilamide) in man. PRIOR JA; SASLAW S J Lab Clin Med; 1951 Sep; 38(3):420-7. PubMed ID: 14880757 [No Abstract] [Full Text] [Related]
16. [Results of puncture and penicillin or elkosin instillation in purulent puerperal mastitis]. LEINZINGER E Wien Klin Wochenschr; 1952 Jan; 64(4):71-3. PubMed ID: 14913951 [No Abstract] [Full Text] [Related]
17. The treatment of streptococcal infections with elkosin N1-(2, 6-dimethyl-4- pyrimidyl) sulfanilamide. MOUTON CM; BOWER AG J Natl Med Assoc; 1952 Nov; 44(6):435-6. PubMed ID: 13000421 [No Abstract] [Full Text] [Related]
18. COMPARISON BETWEEN THE RATE CONSTANTS FOR ACETYLATION OF SULFONAMIDES IN VIVO AND UW PARTITION COEFFICIENT. NELSON E J Med Pharm Chem; 1962 Jan; 5():211-4. PubMed ID: 14046611 [No Abstract] [Full Text] [Related]
19. COMPARISON BETWEEN THE RATE CONSTANTS FOR ACETYLATION OF SULFONAMIDES IN VIVO AND O-W PARTITION COEFFICIENT. NELSON E J Med Pharm Chem; 1962 Jan; 5():211-4. PubMed ID: 14047424 [No Abstract] [Full Text] [Related]
20. The clinical use of sulfisomidine in urinary tract infections. RUTENBURG AM Ann N Y Acad Sci; 1957 Oct; 69(3):389-94. PubMed ID: 13488267 [No Abstract] [Full Text] [Related] [Next] [New Search]